A detailed history of Schroder Investment Management Group transactions in Johnson & Johnson stock. As of the latest transaction made, Schroder Investment Management Group holds 1,656,572 shares of JNJ stock, worth $275 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares
1,656,572
Previous 1,632,661 1.46%
Holding current value
$275 Million
Previous $258 Million 6.25%
% of portfolio
0.28%
Previous 0.31%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$144.38 - $157.78 $3.45 Million - $3.77 Million
23,911 Added 1.46%
1,656,572 $242 Million
Q1 2024

May 14, 2024

BUY
$155.22 - $162.74 $1.99 Million - $2.09 Million
12,819 Added 0.79%
1,632,661 $258 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $47.3 Million - $51.6 Million
-324,891 Reduced 16.71%
1,619,842 $254 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $36.3 Million - $40.6 Million
-232,935 Reduced 10.7%
1,944,733 $303 Million
Q2 2023

Aug 11, 2023

SELL
$154.35 - $166.11 $104 Million - $112 Million
-676,936 Reduced 23.71%
2,177,668 $360 Million
Q1 2023

May 11, 2023

SELL
$151.05 - $180.26 $197 Million - $235 Million
-1,301,167 Reduced 31.31%
2,854,604 $442 Million
Q4 2022

Feb 10, 2023

SELL
$160.2 - $179.79 $19.3 Million - $21.7 Million
-120,622 Reduced 2.82%
4,155,771 $734 Million
Q3 2022

Nov 10, 2022

SELL
$161.33 - $179.52 $51.5 Million - $57.3 Million
-319,080 Reduced 6.94%
4,276,393 $699 Million
Q2 2022

Aug 11, 2022

BUY
$168.19 - $186.01 $37.2 Million - $41.2 Million
221,274 Added 5.06%
4,595,473 $816 Million
Q1 2022

May 16, 2022

BUY
$158.14 - $179.59 $77.3 Million - $87.7 Million
488,600 Added 12.57%
4,374,199 $775 Million
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $97.6 Million - $108 Million
625,627 Added 19.19%
3,885,599 $665 Million
Q3 2021

Nov 12, 2021

SELL
$161.5 - $179.47 $80.2 Million - $89.1 Million
-496,338 Reduced 13.21%
3,259,972 $526 Million
Q2 2021

Aug 13, 2021

SELL
$159.48 - $171.07 $26.5 Million - $28.5 Million
-166,464 Reduced 4.24%
3,756,310 $619 Million
Q1 2021

May 17, 2021

BUY
$153.07 - $170.48 $7.23 Million - $8.05 Million
47,245 Added 1.22%
3,922,774 $645 Million
Q4 2020

Feb 16, 2021

BUY
$137.11 - $157.38 $41.2 Million - $47.3 Million
300,537 Added 8.41%
3,875,529 $610 Million
Q3 2020

Nov 13, 2020

SELL
$140.38 - $153.83 $14.8 Million - $16.2 Million
-105,349 Reduced 2.86%
3,574,992 $523 Million
Q2 2020

Aug 13, 2020

SELL
$128.81 - $155.51 $50.8 Million - $61.3 Million
-394,016 Reduced 9.67%
3,680,341 $518 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $29.2 Million - $40.5 Million
-262,749 Reduced 6.06%
4,074,357 $569 Million
Q4 2019

Feb 11, 2020

SELL
$127.5 - $146.44 $28.5 Million - $32.7 Million
-223,547 Reduced 4.9%
4,337,106 $633 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $43.3 Million - $48.4 Million
340,729 Added 8.07%
4,560,653 $586 Million
Q2 2019

Aug 08, 2019

SELL
$131.15 - $144.24 $78.8 Million - $86.7 Million
-601,070 Reduced 12.47%
4,219,924 $588 Million
Q1 2019

May 14, 2019

BUY
$125.72 - $139.79 $69.2 Million - $76.9 Million
550,396 Added 12.89%
4,820,994 $674 Million
Q4 2018

Feb 14, 2019

SELL
$122.84 - $147.84 $28.6 Million - $34.4 Million
-232,745 Reduced 5.17%
4,270,598 $551 Million
Q3 2018

Nov 13, 2018

SELL
$121.58 - $142.88 $48.9 Million - $57.4 Million
-401,816 Reduced 8.19%
4,503,343 $622 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $2.16 Million - $2.38 Million
-18,097 Reduced 0.37%
4,905,159 $598 Million
Q1 2018

May 11, 2018

BUY
$125.1 - $148.14 $77.9 Million - $92.2 Million
622,686 Added 14.48%
4,923,256 $631 Million
Q4 2017

Feb 09, 2018

BUY
$131.22 - $143.62 $21.2 Million - $23.2 Million
161,663 Added 3.91%
4,300,570 $601 Million
Q3 2017

Nov 09, 2017

BUY
$129.47 - $135.38 $536 Million - $560 Million
4,138,907
4,138,907 $536 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $434B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Schroder Investment Management Group Portfolio

Follow Schroder Investment Management Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

News

Stay updated on Schroder Investment Management Group with notifications on news.